Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes

Tissue Antigens

Volumn 62, Issue 6, 2003, Pages 492-497

  Nielsen, C ^a   Hansen, D ^a   Husby, S ^a   Jacobsen, B B ^a   Lillevang, S T ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Association study; Autoimmunity; Disease susceptibility; Haplotypes; Linkage disequilibrium; PD 1; Single nucleotide polymorphism; Type 1 diabetes

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1;

ADOLESCENT; ALLELE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; RODENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ALLELES; ANTIGENS, CD; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

RODENTIA;

EID: 0344099132     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0039.2003.00136.x     Document Type: Article

References (21)

1. Prokunina L, Castillejo-Lopez C, Oberg F et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666-9.
2. Okazaki T, Maeda A, Nishimura H et al. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 2001; 98: 13866-71.
3. Bennett F, Luxenberg D, Ling V et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and H-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003; 170: 711-8.
4. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116-26.
5. Hawa MI, Beyan H, Buckley LR, Leslie RD. Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet 2002; 115: 8-17.
6. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002; 3: 235-49.
7. Nishimura H, Okazaki T, Tanaka Y et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319-22.
8. Nishimura H, Nose M, Hiai H et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-51.
9. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
10. Schneider S, Roessli D, Excoffier L. Arlequin: A software for population genetics data analysis. Version 2.000. Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva 2000.
11. Meyers S, Downing JR, Hiebert SW. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 1993; 13: 6336-45.
12. Okuda T, Nishimura M, Nakao M, Fujita Y. RUNX1/AML1: a central player in hematopoiesis. Int J Hematol 2001; 74: 252-7.
13. Lutterbach B, Hiebert SW. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 2000; 245: 223-35.
14. + T cell levels in NOD mice. Proc Natl Acad Sci U S A 2002; 99: 12287-92.
15. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 1212-8.
16. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-40.
17. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31: 1247-54.
18. high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-53.
19. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-10.
20. Gray CP, Arosio P, Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002; 99: 3326-34.
21. Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-34.